2 Results for "

ch5132799

" in MedChemExpress (MCE) Product Catalog:
Products (2)

2 Results for "ch5132799" in MCE Product Catalog:

3
3 Cited Publications
Cat. No.: HY-15466
CAS No.: 1007207-67-1
Purity:  99.01%
Synonyms: ch5132799
Target:  

PI3K Apoptosis mTOR Akt

Research Areas:  

Cancer

Izorlisib (CH5132799) is an orally active, selective Class I PI3K inhibitor with an IC50 value of 14 nM against PI3Kα. Izorlisib specifically inhibits Class I PI3K (particularly PI3Kα and its mutants) and blocks the PI3K/Akt/mTOR pathway; this leads to cell cycle arrest at the G1 phase and apoptosis without triggering feedback activation of Akt by competitively binding to the ATP-binding site of PI3K. Izorlisib can be used in research on cancers harboring PIK3CA mutations or PTEN loss (such as breast, ovarian, prostate, and endometrial cancers) .
loading...
    loading...
Cat. No.: HY-15466A
CAS No.: 2242053-82-1
Synonyms: ch5132799 methanesulfonate
Target:  

PI3K Apoptosis mTOR Akt

Research Areas:  

Cancer

Izorlisib (CH5132799) methanesulfonate is an orally active, selective Class I PI3K inhibitor with an IC50 value of 14 nM against PI3Kα. Izorlisib methanesulfonate specifically inhibits Class I PI3K (particularly PI3Kα and its mutants) and blocks the PI3K/Akt/mTOR pathway; this leads to cell cycle arrest at the G1 phase and apoptosis without triggering feedback activation of Akt by competitively binding to the ATP-binding site of PI3K. Izorlisib methanesulfonate can be used in research on cancers harboring PIK3CA mutations or PTEN loss (such as breast, ovarian, prostate, and endometrial cancers) .
loading...
    loading...